Last checked at 21 Mar 22 14:38
TRADING UPDATES: Further progress at Blencowe and Rockfire mines
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:...
Read more
- Home
- Share Prices
- AQSE Share Prices
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Media & Events
- Brokers
- Finance Tools
- Members
Latest Share Chat
Shield Thera Share News (STX)
STX Share
Price
STX Share
News
STX Share
Chat
STX Share
Trades11
STX
Live RNS
STX Share
Charts
STX Level 2
Console
STX Live
Share Price
STX Broker
Ratings
STX Directors
Deals
STX Financial
Diary
STX
Fundamentals
STX Short
Positions
STX
Media
STX Information
Share Price Information for Shield Thera (STX)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
13.00
Bid:
12.50
Ask:
13.50
Change: 0.00 (0.00%)
Spread:
1.00 (8.00%)
Open:
13.00
High:
13.00
Low:
13.00
Prev. Close:
13.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.21 Mar 22 11:58
Shield's Canadian partner files new drug submission for Accrufer
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that KYE Pharmaceuticals has submitted a new drug submission to Health Canada, for the regulatory rev...
Read more17 Feb 22 15:51
Shield Therapeutics revenue falls in line with expectations
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported total 2021 revenue of £1.5m in a trading update on Thursday, in line with market expectations....
Read more17 Feb 22 11:54
Shield Therapeutics shares fall as guides for sharp 2021 revenue drop
(Alliance News) - Shield Therapeutics PLC's shares tumbled on Thursday after a trading update revealed a substantial, but expected, fall in revenue....
Read more5 Jan 22 13:43
Shield Therapeutics enters Accrufer licensing deal in Canada
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Wednesday, with KYE Pharmaceuticals in Ca...
Read more5 Jan 22 10:35
Shield Therapeutics signs license agreement in Canada for lead product
Shield Therapeutics signs license agreement in Canada for lead product...
Read more16 Dec 21 15:21
Shield shares surge on expansion of US coverage for Accrufer
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on progress made on payer coverage of 'Accrufer' in the United States on Thursday....
Read more16 Dec 21 10:56
AIM WINNERS & LOSERS: Wressle boosts Europa Oil, Egdon and Union Jack
AIM WINNERS & LOSERS: Wressle boosts Europa Oil, Egdon and Union Jack...
Read more27 Sep 21 14:26
Shield Therapeutics appoints chief medical officer
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that Dr Jose Menoyo is joining its senior executive team as vice-president and chief medical officer,...
Read more27 Sep 21 14:17
EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec
EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec...
Read more17 Aug 21 12:00
Shield Therapeutics swings to losses in first half
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported first-half revenues of £0.5m in its interim results on Tuesday, falling from £8.9m year-on-year....
Read more17 Aug 21 11:23
AIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal
AIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal...
Read more17 Aug 21 10:57
Shield Therapeutics shares fall as swings to loss in first half
Shield Therapeutics shares fall as swings to loss in first half...
Read more12 Aug 21 19:25
TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE
TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE...
Read more12 Aug 21 12:25
Shield Therapeutics inks exclusive licence for 'Accrufer' in Korea
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Thursday, with Korea Pharma in South Kore...
Read more